Current Programs
HomeCurrent Programs
GBM AGILE
February 16, 2026 Current Programs, Global Collaborative Platforms
GBM – One of the Most Deadly Cancers
GBM continues to face limited treatment options and devastating survival rates.
AFCR is committed to accelerating breakthrough solutions.
The Urgent Need for Innovation
95%
GBM kills 95% of patients
within five years of diagnosis
240,000
Each Year,…
AFCR Symposium at BIOHK
February 16, 2026 Current Programs, Global Collaborative Platforms
BIOHK: Advancing Global Cancer Innovation
AFCR’s Partnerships with the Hong Kong Biotechnology Organization (HKBIO) and CityU - Aim to Unlock Hong Kong’s Potential as a Biomedical Innovation Hub
2022
2023
2024
2022 Think-Tank Forum for Advancing Biomedical Development in
Hong Kong
2023 AFCR-BIOHK Symposium on…
A Breakthrough Approach to “Undruggable” Targets
THE CHALLENGE: Undruggable Targets In Cancer
Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…
Building Safer, More Effective CAR-T Cell Therapies for Cancer Patients
August 16, 2022 Current Programs, Innovative Therapies and Treatments, Translational Research
CAR-T Cell Therapies are Not Working Against Solid Cancers
Doctors divide cancer into two main types: solid tumor cancers and cancers in the blood. Solid cancer is an abnormal mass of tissue in a ‘solid’ organ such as the breast or prostate.…
Revolutionary Drug Delivery Platform: Improves Effectiveness and Tolerability of Cancer Treatments
November 15, 2021 Current Programs, Innovative Therapies and Treatments, Translational Research
THE CHALLENGE ——Patient Circumstances Limit Potential Viable Therapies
Patients afflicted with tumors and cancers are in need of urgent, active intervention in order to have the best possibilities for treatment success and a favorable outcome. The majority of such patients often present…
Changing the Oncology Treatment Paradigm For Oral Cancers
September 13, 2021 AFCR News, Clinical Research, Current Programs, Innovative Therapies and Treatments
THE CHALLENGE ——Oral Cancer Survival Rate Has Only Improved 5% in the Last Decade and Patients Can Have a Severely Compromised Quality of Life
Oral cancers, a type of Head and Neck cancer, include the lip, tongue, gums, cheeks, the floor (bottom)…
THE CHALLENGE
——High Incidence and Mortality, Few Viable and Dedicated Drugs
Gastrointestinal (GI) cancers including colorectal, stomach, liver, esophageal, and pancreas have high incidence and mortality. Globally, they have the 2nd, 3rd, 4th, 6th, and 7th largest death tolls, respectively, among all cancers.
In 2020,…
Convergence of Western Science and Traditional Chinese Medicine — Botanical Cancer Drug Platform
April 13, 2021 AFCR News, Clinical Research, Current Programs, Innovative Therapies and Treatments
THE CHALLENGE
—Unmet Medical Need for Holistic Cancer Treatment
Cancer is a heterogeneous disease. Heterogeneity in cancer is not limited to differences between different patients, but also occurs within a single patient. This intrapatient or intratumoral heterogeneity can present great challenges for cancer treatment.
This…
Advanced cancers typically suppress the immune response by multiple mechanisms. By carefully engineering multi-functional antibody therapies, there is the potential for more effective treatment.
PIONEER Oncology
May 27, 2025
Pioneer Oncology
HomePioneer Oncology
Advancing Early-Stage Translational Clinical Trials A disruptive first-in-human clinical trials platform to transform Cancer treatment landscape and accelerate the development of effective therapies. The knowledge, methodologies, and infrastructure built through this initiative will serve as a scalable model for…